ESR1 and breast cancer: In agreement with our in vitro data, ChIP–qPCR analysis demonstrate a significant increase in H3K27ac signal in a biopsy derived from a metastatic deposit (AI resistant) compared wih a sample derived from a primary, drug-sensitive ERα breast cancer patient (Fig. 4g).